Polymer Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Polymer Capital Management's BMY Position: Q2 2026 in Review
Polymer Capital Management increased its Bristol-Myers Squibb (BMY) stake by 9.3% in Q2 2026, buying an estimated $32.3K and bringing the position to 6,585 shares worth $379K. The position accounts for 0.05% of the portfolio, ranked #471.
Polymer Capital Management first reported a position in BMY in Q3 2025 and has held it in 4 quarters since. The position peaked at $590K in Q4 2025. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Polymer Capital Management held 6,585 shares of Bristol-Myers Squibb worth $379K as of Q2 2026.
- Polymer Capital Management bought 562 Bristol-Myers Squibb shares in Q2 2026, an estimated $32.3K.
- Bristol-Myers Squibb made up 0.05% of Polymer Capital Management's portfolio in Q2 2026, its #471 holding.
- Polymer Capital Management first reported a position in Bristol-Myers Squibb in Q3 2025 and has held it in 4 quarters since.
- Polymer Capital Management's Bristol-Myers Squibb position peaked at $590K in Q4 2025.
- 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Polymer Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.